JR1152-F TLD and CDP are credible in checking 3D-dose distributions of 192Ir HDR intracavitary after-loading brachytherapy for patients with cervical carcinoma.

• 3D-BSS准确可靠,用JR1152-F型TLD和仿真人体盆腔模型验证宫颈癌腔内后装治疗三维剂量分布具有可行性。